BIOPHARMACEUTICALS

	Patent expirations are beckoning generic drug companies, but numerous hurdles remain to a profitable business http://pubs.acs.org/cen/coverstory/83/8323biopharmaceuticals.html Chemical & Engineering News June 6, 2005 Volume 83, Number 23 pp. 21-29